Univest
Univest
  • Markets

Titan Brokerage Rating Stays Bullish as Citi and Nomura Both Retain Buy After Strong Q1 FY27 Update

  • July 7, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Titan Brokerage Rating

Titan brokerage rating: Citi buy, target Rs 5,075. Nomura buy, target Rs 5,000. Both cite Q1 jewellery growth of 39% YoY, Caratlane +42%, strong festive demand. Stock at Rs 4,605.20, up 2.7%.

The Titan brokerage rating consensus turned firmly bullish on 7 July 2026, with both Citi and Nomura reiterating buy calls on the jewellery major following its Q1 FY27 business update. Citi retained its buy rating with a target price of Rs 5,075, while Nomura kept its own buy rating with a target of Rs 5,000. Titan Company shares rallied on the back of both notes, quoting at Rs 4,605.20, up 2.69 percent, after touching a fresh 52-week high of Rs 4,655.

Both brokerages pointed to the same underlying strength: domestic jewellery, excluding bullion, grew 39 percent year on year in Q1, ahead of estimates and driven by robust festive demand around Akshaya Tritiya, while Caratlane’s online-first format grew 42 percent.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Titan Brokerage Rating Comparison: Citi vs Nomura
  • What’s Driving This Bullish Titan Brokerage Rating Consensus
  • Titan Share Price Reaction to This Bullish Brokerage Rating
  • What to Watch Next for the Titan Brokerage Rating
  • Conclusion
  • Frequently Asked Questions on the Titan Brokerage Rating
    • What is the latest Titan brokerage rating from Citi and Nomura?
    • Why are both brokerages bullish on Titan?
    • What is the Titan share price today?
    • How many jewellery stores did Titan add in Q1 FY27?
    • What is the upside implied by these Titan brokerage targets?
    • How did Caratlane perform according to these notes?
    • Should investors buy Titan based on these brokerage ratings?

Titan Brokerage Rating Comparison: Citi vs Nomura

Parameter Citi Nomura
Rating Buy (maintained) Buy (maintained)
Target Price Rs 5,075 Rs 5,000
Key Driver Cited Domestic jewellery (ex-bullion) up 39% YoY, ahead of estimates Strong Q1 performance across all business segments
Demand Commentary Growth driven by festive demand and Akshaya Tritiya Jewellery growth exceeds estimates, led by domestic business and Caratlane
Other Segments Noted Watches, eyecare and emerging businesses post healthy growth Watches and eyecare outperform expectations
International Business Not separately flagged in this note Continues strong growth momentum

What’s Driving This Bullish Titan Brokerage Rating Consensus

Citi’s note highlights that Titan added 22 jewellery stores in Q1 alone, with buyer growth in early double digits and ticket sizes remaining strong, evidence that the growth is broad-based across both new customer acquisition and higher spending per customer. Nomura’s parallel note emphasises that jewellery growth exceeded its own estimates, led by both the domestic business and Caratlane, while flagging that watches and eyecare also outperformed expectations.

The alignment between two independent brokerages arriving at similar bullish conclusions, even with a modest Rs 75 gap between their price targets, reinforces the market’s reading that Titan’s Q1 FY27 update was a genuinely strong, broad-based print rather than a narrow beat driven by one segment.

Get Research-Backed Stock Ideas from a SEBI Registered Investment Advisor

Titan Share Price Reaction to This Bullish Brokerage Rating

Titan shares touched a fresh 52-week high of Rs 4,655 in today’s session, confirming that the stock market has embraced this bullish Titan brokerage rating. With Citi’s target of Rs 5,075 implying further upside of around 10 percent and Nomura’s Rs 5,000 target implying about 8.6 percent upside from current levels, both notes suggest room for the rally to continue, even after today’s near-3 percent gain.

What to Watch Next for the Titan Brokerage Rating

Investors tracking this Titan brokerage rating should watch the detailed Q1 FY27 financial results for margin delivery, given that revenue growth alone does not guarantee proportionate profit growth in a gold price inflation environment. International business momentum, which Nomura specifically flagged as continuing strong, along with the pace of new store additions, will also be key data points as more brokerages weigh in with their own Titan brokerage rating updates.

Download the Univest iOS App or Univest Android App to track Titan live and get brokerage rating updates daily.

Conclusion

The Titan brokerage rating picture turned decisively bullish on 7 July 2026, with Citi maintaining buy at a Rs 5,075 target and Nomura maintaining buy at Rs 5,000, both citing a strong, broad-based Q1 FY27 update led by 39 percent jewellery growth and a 42 percent jump at Caratlane. Titan shares touched a fresh 52-week high of Rs 4,655 on the back of the twin endorsements. Margin delivery in the detailed results is the next checkpoint for both brokerages’ theses.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on the Titan Brokerage Rating

What is the latest Titan brokerage rating from Citi and Nomura?

Ans. Citi has maintained a buy rating on Titan with a target price of Rs 5,075, while Nomura has also maintained a buy rating with a target of Rs 5,000, both following the company’s strong Q1 FY27 business update.

Why are both brokerages bullish on Titan?

Ans. Both Citi and Nomura cite Titan’s strong, broad-based Q1 FY27 performance, including domestic jewellery growth of 39 percent year on year, Caratlane growth of 42 percent, and healthy momentum across watches, eyecare and international business.

What is the Titan share price today?

Ans. Titan Company was quoting at Rs 4,605.20 on 7 July 2026, up 2.69 percent, after touching a fresh 52-week high of Rs 4,655 during the session.

How many jewellery stores did Titan add in Q1 FY27?

Ans. According to Citi’s note, Titan added 22 jewellery stores in Q1 FY27, part of the broad-based growth that impressed both brokerages.

What is the upside implied by these Titan brokerage targets?

Ans. Citi’s target of Rs 5,075 implies upside of around 10 percent from current levels, while Nomura’s target of Rs 5,000 implies upside of about 8.6 percent.

How did Caratlane perform according to these notes?

Ans. Both Citi and Nomura highlighted Caratlane’s strong performance, with Citi specifically noting 42 percent year-on-year growth for the online-first jewellery format.

Should investors buy Titan based on these brokerage ratings?

Ans. This article does not constitute investment advice. Brokerage targets should be weighed alongside detailed financial results, margin trends and valuations. Consult a SEBI registered financial advisor before investing.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply